Abstract
Background
Chlamydia trachomatis is one of the most frequently reported sexually transmitted infections (STI) in Australia, the UK and Europe. Yet, rates of screening for STIs remain low, especially in younger adults.
Objective
To assess effectiveness of Chlamydia screening interventions targeting young adults in community‐based settings, describe strategies utilized and assess them according to social marketing benchmark criteria.
Search strategy
A systematic review of relevant literature between 2002 and 2012 in Medline, Web of Knowledge, PubMed, Scopus and the Cumulative Index to Nursing and Allied Health was undertaken.
Results
Of 18 interventions identified, quality of evidence was low. Proportional screening rates varied, ranging from: 30.9 to 62.5% in educational settings (n = 4), 4.8 to 63% in media settings (n = 6) and from 5.7 to 44.5% in other settings (n = 7). Assessment against benchmark criteria found that interventions incorporating social marketing principles were more likely to achieve positive results, yet few did this comprehensively. Most demonstrated customer orientation and addressed barriers to presenting to a clinic for screening. Only one addressed barriers to presenting for treatment after a positive result. Promotional messages typically focused on providing facts and accessing a testing kit. Risk assessment tools appeared to promote screening among higher risk groups. Few evaluated treatment rates following positive results; therefore, impact of screening on treatment rates remains unknown.
Discussion
Future interventions should consider utilizing a comprehensive social marketing approach, using formative research to increase insight and segmentation and tailoring of screening interventions. Easy community access to both screening and treatment should be prioritized.
Keywords: Chlamydia, consumer orientation, screening, sexual health, social marketing
Introduction
Chlamydia trachomatis (CT) is one of the most frequently reported sexually transmitted infections (STI) in Australia,1 the UK2 and in Europe.3 International prevalence studies highlight that sexually active adults under the age of 30 years are most at risk of infection.3 If CT is left untreated, it can lead to serious conditions such as pelvic inflammatory disease and tubal infertility in females; epididymitis, urethritis and proctitis in males.4 Reducing the rates of STIs such as Chlamydia is therefore an important public health and social priority across the world.5
The main risk factors for CT in sexually active females are as follows: age (<25 years), inconsistent use of barrier contraceptives (e.g. condoms), multiple sexual partners, cervical ectopy and a history of STI or a co‐existing STI.4 Many existing strategies to reduce infection rates have focused on awareness raising and behaviour changes relating to condom use. Because CT is asymptomatic in about 80% of cases, screening can also provide an effective method of early detection. In the US and Australia, sexual health guidelines recommend annual CT screening in primary care for all sexually active females aged between 15 and 25 years, and for sexually active young males in high risk groups or clinical settings (e.g. adolescent clinics, correctional facilities, STD clinics).6, 7, 8 However, only a limited number of countries have taken a systematic approach to effect Chlamydia control and only 13 of 29 countries in Europe have national guidelines for screening, diagnosis and management.9
Chlamydia trachomatis screening is non‐invasive and typically involves a urine test or swab for females, and a urine test for males. In Australia, CT screening most commonly occurs through opportunistic screening during a GP consultation. The 2007/2008 national GP CT testing rate per 100 sexually active individuals was 8.0%, although it was considerably higher in females (12.5%) compared with males (3.7%).10 In the US, significant improvements in the Chlamydia screening rates have been achieved through targeted programmes with effective rates of 45% for insured and 58% for Medicaid‐covered sexually active women aged 16–24 years.11 Whilst there are significant variations internationally in screening and surveillance programmes, what it clear is that screening rates remain lower in younger adults and at risk groups than the desired target rates.9, 10, 11, 12
Despite the availability of non‐invasive testing methods and highly effective medical treatments, rates of screening for STIs remain low in younger adults.10 Whilst screening in primary care settings may be improved by the universal offer of screening to some patients,13 Low et al.14 found that there was little evidence to support opportunistic CT screening across settings for young people aged less than 25 years. This creates an imperative to develop insight and evaluate the features of interventions that can more effectively promote CT screening and engage this younger demographic.
Previous sexual health research15 and current government sexual health policies in countries such as the UK16 have highlighted that gaining the consumer (or participant) perspective is central to understanding how to increase the utilization of sexual health screening programmes. This mirrors a wider recognition of the importance of consumer orientation in public health service delivery.16, 17 Social marketing is a strategic framework that has successfully utilized a consumer‐centred approach to support attitudinal and behaviour change at a group or community level across numerous health issues.18, 19 Therefore, it may have utility in facilitating access and use of Chlamydia screening among young people in the community.
This article presents the findings from a systematic literature review that examines current evidence regarding the nature and effectiveness of consumer approaches to promote opportunistic CT screening within a range of community settings to engage young people (<30 years). Whilst a recent review investigated home‐based Chlamydia and gonorrhoea screening strategies and outcomes,20 this study is the first to evaluate the approaches within a variety of ‘non‐clinical’ community settings. Furthermore, although current CT interventions use a variety of frameworks and approaches, social marketing has been suggested as a particularly relevant and promising approach to sexual health programmes. The present systematic review also assesses included interventions against recognized social marketing benchmark criteria.21 Whilst it is important to acknowledge that included interventions may not have been planned using the social marketing framework, this assessment can help identify strengths and weaknesses in current approaches and identify useful strategies for future interventions. This approach has been used in previous reviews on the effectiveness of behaviour change interventions for other health issues.19, 22
Social marketing is a systematic framework that uses marketing principles to promote socially beneficial behaviour change.23 It is distinctive from other approaches as it is consumer orientated and facilitates change by enhancing the benefits associated with the behaviour and minimizing the costs.23 Well‐designed social marketing programmes have been effective in promoting health behaviour change in relation to substance misuse, food and nutrition and physical activity;19, 22 and other screening behaviours, for example, colorectal cancer.24 Given the effectiveness of social marketing in other health behaviours, it is appropriate to investigate the utility of its principles to promote CT screening. Whilst the majority of interventions in the systematic review were not conceptualized according to social marketing principles, the social marketing benchmarking criteria provide insight into the relative strengths and weaknesses of existing interventions from this perspective. Furthermore, this allows for recommendations for the development of future CT screening that could utilize social marketing as a framework.
Method
A systematic literature search using the databases Medline, Web of Knowledge, PubMed, Scopus and the Cumulative Index to Nursing and Allied Health was conducted to identify published behavioural interventions to increase Chlamydia screening. The following terms were used to search for academic peer‐reviewed published articles published in English from January 2002 to June 2012: ‘Chlamydia AND (screen or screening or intervention* or social marketing or program* or campaign)’. Titles and abstracts were screened by two reviewers to identify potentially relevant articles. Reference lists of identified articles were also searched to identify any additional relevant papers. Full‐text articles were read independently by two of the authors to ensure consensus was reached on the final articles to be included. Studies were included if they measured CT screening behaviour (not just knowledge or beliefs), targeted CT screening only1, targeted people under 30 years of age and were implemented in non‐clinical settings. Whilst it is noted that national population screening rates are often provided for a more limited age range (15–24 years), many of the relevant research studies included people aged from 15 to 30 years and were included to ensure all relevant literature was reviewed.
Exclusion criteria were as follows: educational or awareness raising programmes with no behaviour change objectives, poster presentations and review articles, and non‐academic and unpublished grey literature. Whilst included studies may have also aimed to change knowledge or beliefs, the focus of this study was on reviewing interventions in relation to their effectiveness in promoting CT screening and follow‐up in at‐risk segments, and investigating the settings and strategies used. The three primary behavioural outcome measures reported included number of tests (as a proportion of those exposed to the intervention), positivity rate (as a proportion of those tested) and treatment rates were reported (as a proportion of those who tested positive). Behaviours such as ‘logging on to a website’ or ‘downloading’ information or forms were also noted if reported. Finally, consistent with the objectives of the systematic review, an overall consensus about the interventions was reached by two of the reviewers. All interventions were judged against three primary behavioural outcomes: the proportional screening rates, the number of positive tests and the ability of the intervention to support treatment in participants who tested positive (also reported as a proportional rate). Interventions included in the systematic review were also assessed against the UK National Social Marketing Centre's Social Marketing National Benchmark Criteria.16 The benchmark criteria present eight integrated elements that should be featured in a comprehensive social marketing intervention (see Table 1). Interventions were also evaluated for quality on the basis of study design and outcome measures using the GRADE protocol.25 Coders met periodically during the process, and intercoder reliability checks were conducted on the entire sample between the two researchers. The coefficient of agreement [the total number of agreements (n = 17) divided by the total number of coding decisions (n = 20)] was 85%, and a third researcher resolved any disagreements.
Table 1.
Outline of the social marketing national benchmark criteria (French, Blair‐Stevens, 2005)
| Benchmark | Description |
|---|---|
| Behaviour | The intervention needs to have a clear focus on a specific behaviour (e.g. CT screening), not merely psychological factors such as attitudes or intentions. There needs to be a detailed understanding of the ‘problem’ and ‘desired’ behaviours. |
| Customer Orientation | The intervention should be informed by a broad and robust understanding of the customer. Formative research and pre‐testing are important in identifying consumer characteristics and needs. |
| Theory | Interventions should be informed by relevant behavioural theories that are used to understand the target behaviour (e.g. beliefs, barriers). |
| Insight | Formative research should lead to an insight into the factors that influence behaviour (e.g. psychological and physical barriers). This insight is important for developing the intervention, and in particular addressing issues surrounding exchange and competition. |
| Exchange | This involves understanding the benefits and costs to the individual of behaviour change and maintenance. In particular, there is a need for the intervention to maximize the benefits and minimize the costs to make the behaviour change attractive to the individual. |
| Competition | This element recognizes that lots of different factors compete for the individual's time and attention; these can impede behaviour change. The intervention therefore needs to minimize the impact of competition, which could be achieved through maximizing the value of the exchange. Development of strategies that aim to minimize the potential impact of the competition. |
| Segmentation | The target ‘audience’ is not homogeneous and may have different attitudes, beliefs and barriers which have the potential to influence intervention success. As a result, it is important to identify subpopulations (i.e. segments) that share similar geographic, psychological and behavioural characteristics. Interventions should be tailored according to the distinct characteristics of these segments. |
| Methods Mix | This final element emphasizes the importance of using a range of different methods to promote behaviour change. That is, interventions cannot merely rely on education and also need to incorporate elements of the marketing mix (i.e. product, place, promotion and price). |
Results
The search strategy yielded a total of 10 593 references (see Fig. 1). After excluding duplicates and papers not fulfilling the inclusion criteria, 30 full‐text articles were reviewed with a further seven studies identified from references list searches. Of these 37 articles, 17 papers in primary care or hospital settings were excluded. However, two programmes which offered a choice of clinic or community‐based screening were included.26, 27 A final total of 20 papers were included in the systematic review.
Figure 1.

Flowchart.
From the 20 papers, 18 interventions were reported on (two papers from Gaydos et al.28, 29 were both reporting results from the same intervention, and van Bergen et al.30 and van den Broek et al.31 were also two papers reporting on the same intervention). The interventions were conducted in the following settings: pharmacies,32, 33, 34, 35 high schools,36, 37 universities,38, 39 Internet‐based28, 29, 40 and media‐based campaigns.26, 27 However, these are difficult to strictly categorize as many interventions were conducted across settings. Intervention designs included one RCT,41 two quasi‐experimental studies,39, 42 two pre‐ and post (no control)‐evaluations designs31, 34, 43 and six cross‐sectional/post‐test designs.27, 32, 33, 38, 44, 45 The remaining eight interventions did not explicate study designs, but could be described as observational or descriptive designs.28, 29, 35, 36, 37, 40, 46, 47 Most targeted adolescents and young adults (14–29 years) although some only specified an adult target group, or no target group (as they were observational studies). Five had specific gender target groups, three females only28, 35, 36 and two males only.40, 45 Audiences were also targeted within particular settings or groups, for example. pharmacy customers,32, 33, 35 music festival attendees,44 high‐school students36, 37 and men who were members of a private health fund45 or those living within specific geographic regions. Three interventions targeted disadvantaged communities one multicultural neighbourhood,34 one disadvantaged school37 and one rural high school.36 Three interventions also targeted people performing other non‐STI‐related health behaviours, for example those attending a health clinic38 and young women buying oral contraceptives from a pharmacy (Table 2).34, 35
Table 2.
Summary of articles Chlamydia trachomatis (CT) screening interventions in community settings
| Study | Description | Outcomes |
|---|---|---|
|
Aldeen et al. (2010) UK38 |
Target: University students | Overall: Mixed results |
| CT tests: Urine(males), Vaginal swab (females) |
Outcomes measuresa
Number of tests: 88 (35.2%) Positivity: 4.2% Treatment: N/A |
|
| Setting: University clinic | ||
| Design: Cross‐sectional | ||
|
Alicea‐Alvarez et al. (2011) US36 |
Target: Adolescent females |
Overall: Mixed Results Outcomes measures Number of tests: 51/165 (30.9%) Positivity: N/A Treatment: N/A |
| CT tests: Urine test | ||
| Setting: High‐school clinic | ||
| Design: Cross‐sectional | ||
|
Andersen et al. (2002) Denmark41 |
Target: Males and females aged 21–23 years |
Overall: Mixed results Outcome measures Number of tests: 771 (38.6%) and 659 (33%) Positivity: 42 (6.5%) and 42 (8%) Treatment: N/A |
| CT tests: Home vaginal swab | ||
| Setting: Country region | ||
| Design: Randomized control trial | ||
|
Anderson et al. (2011) UK32 |
Target: Adults |
Overall: Positive effect Outcome measures: Number of tests: 14 378 (2 years) Positivity: 1131/14 378 (0.8%) Treatment: 533/1131 (47.1%) |
| CT tests: Home urine test | ||
| Setting: Pharmacy | ||
| Design: Cross‐sectional | ||
|
Barry et al. (2008) US37 |
Target: Adolescents (male and female) |
Overall: Mixed results Outcomes measures Number of tests: 537/967 (63%) Positivity: 1.3% (identified at risk) Treatment: N/A |
| CT tests: Urine test | ||
| Setting: High‐school clinic, disadvantaged area | ||
| Design: Cross‐sectional | ||
|
Brabin et al. (2009) UK35 |
Target: Females <25 years requesting contraception |
Overall: Mixed results Outcome measures Number of tests: 264/1348 (17.6%) Positivity: 24/264 (9.1%) Treatment: 22/24 (91.7%) |
| CT tests: Home Urine Test | ||
| Setting: Pharmacy | ||
| Design: Quasi‐experimental | ||
|
Chai et al. (2010) US40 |
Target: Males >14 |
Overall: Positive results Outcomes measures Number of tests: 512 (31%) Positivity: 64/501 (13%) Treatment: N/A |
| CT tests: Home urine test | ||
| Setting: Internet based | ||
| Design: Cross‐sectional | ||
|
Chen et al. (2007) Australia26 |
Target: 16–29 years |
Overall: Mixed results Outcomes measures Number of tests: 2842 (men) and 6049 (women) Not reported Positivity: 1.9% (men) and 4.3% women Treatment: N/A |
| CT tests: Existing services | ||
| Setting: Media campaign. | ||
| Design: Cross‐sectional | ||
|
Emmerton et al. (2011) Australia33 |
Target: Adults |
Overall: Mixed Results Outcomes measures Number of tests: 18/156 (12%) Positivity: N/A Treatment: N/A |
| CT Tests: Home urine test | ||
| Setting: Pharmacy | ||
| Design: Cross‐sectional | ||
|
Gaydos et al. (2006, 2009) US28, 29 |
Target: Females >14 years |
Overall: Positive effect Outcomes measures Number of tests: 1254b (32%) (Wave 1) 3774b (32.4%) (Wave 2) Positivity: N/A Treatment: N/A |
| CT Test: Home vaginal swab | ||
| Setting: Regional, Internet Campaign | ||
| Design: Cross‐sectional/Observational | ||
|
Jones et al. (2007) South Africa42 |
Target: Women – aged 14–25 years |
Overall: Positive effect Outcomes measures CT tests: Clinic 131b (42%); Home 143b (47%) Positivity: 22% Treatment: N/A |
| CT Test: Clinic or home vaginal swab | ||
| Setting (s): Mail and clinic | ||
| Design: Quasi‐experimental | ||
|
Kwan et al. (2012) Australia43 |
Target: Not specified |
Overall: Positive effect Outcomes measures CT Request form downloaded: 675 CT Tests: 378/675 (56%) Positivity: 378b (18%) Treatment: 50%b within 7 days |
| CT Tests: Urine test (males), vaginal swab (females) | ||
| Setting: Website | ||
| Online intervention to promote self‐risk assessment, testing and referral for treatment (n = 675) | ||
|
Novak and Karlsson (2006) Sweden47 |
Target: Not specified |
Overall: Low‐moderate results Outcomes measures 19 518 website visits CT Test Requests: 1405/256, 886 (0.4%) CT Tests: 906/1405 (62.5%) Positivity: N/A Treatment: N/A |
| CT Test: Home Urine Test | ||
| Setting: Website | ||
| Design: Cross‐sectional | ||
|
Oh et al. (2002) US46 |
Target: Males and Females 15–25 years |
Overall: Low‐moderate results Outcomes measures Hotline use: 642 calls (Average 99 calls/week vs. 9 calls per week pre‐campaign) CT tests: 31/642 callers (4.8%) Positivity: N/A Treatment: N/A |
| CT Test: Home Urine Test | ||
| Setting: Media Campaign | ||
| Design: Cross‐sectional | ||
|
Sacks‐Davis et al. (2010) Australia44 |
Target: males and females aged 16–29 years |
Overall: Low‐moderate results Outcomes measures Number of tests: 67/313 (21%) Positivity: 1/67 (1%) Treatment: N/A |
| CT Test: Home‐Urine Test (males); Home – vaginal swab (females) | ||
| Setting: Music festival | ||
| Design: Cross sectional study | ||
|
Scholes et al. (2007) US45 |
Target: Men |
Overall: Low results Outcomes measures CT Tests: 5.7% Positivity: N/A Treatment: N/A |
| CT Test: Home Urine Test | ||
| Setting: Health fund members | ||
| Design: RCT | ||
|
van Bergen et al. (2004) Netherlands40 |
Target: Females (15–29 years) collecting contraceptives |
Overall: Moderate results Outcomes measures Number of tests: 73/270 (27%) Positivity: 4.2% Treatment: N/A |
| CT Test: Home Urine Test | ||
| Setting: Pharmacy, Low income area | ||
| Design: Cross‐sectional | ||
|
Vaughan et al. (2010) Ireland39 |
Target: 18–29 years |
Overall: Positive effect Outcomes measures Number of tests: 592/1249 (47.5%) Positivity: 21/358 (3.9%) Treatment: 18/21 (87%) |
| CT Test: Clinic Urine Test | ||
| Setting: University | ||
| Design: Quasi‐experimental | ||
|
van Bergen et al. (2010)c, 30
van den Broek et al. (2010) Netherlandsc, 31 |
Target: 16–29 |
Overall: Low results Outcomes measures CT Tests: 73/270 (27%) Positivity: 4.2% Treatment: N/A |
| CT Test: Home‐Urine Test (males); Home – vaginal swab (females) | ||
| Setting: Website | ||
| Design: Cross‐sectional | ||
|
Wilkins and Mak (2007) Australia27 |
Target: 15–24 years |
Overall: Moderate – positive effect Outcomes measures: CT Tests: females (21%b); males (29%b) Positivity: Females (12%b); males (4%b) Treatment: N/A |
| Clinic urine test (males), clinic vaginal swab (females) | ||
| Setting: Media | ||
| Design: Cross‐sectional |
Studies may have also reported changes in knowledge or attitudes etc; however, only behavioural outcomes are reported.
Only percentages reported.
For interventions with more than one publication, the most recent results are reported.
Effectiveness of interventions on screening, positivity rates and treatment rates
In relation to uptake of CT screening, nine were judged as having a high impact,28, 29, 32, 36, 37, 38, 39, 40, 41, 42 three a moderate impact27, 34, 35, 44 and five a low impact on screening rates.30, 31, 33, 45, 46, 47 Three of the four interventions that achieved a higher positivity rate included a formal risk assessment for participants as part of their strategy to promote testing in higher risk groups.27, 40, 43 None of the interventions with lower rates of positive tests included such a formal risk assessment.
Of the 11 interventions where participants had a positive test result, only four reported the number of those who accessed treatment.32, 35, 39, 43 This ranged from 47.1 to 91% of those who had tested positive for Chlamydia following participation in the intervention.
Social marketing benchmark criteria
Each of the included interventions was evaluated against the social marketing benchmark criteria (see Table 3). Of the nine interventions found to have a positive impact, two36, 39 met seven of the eight social marketing benchmark criteria, but did not report the theory utilized, and one met six criteria, but did not report the use of theory or segmentation.29 Another intervention met five benchmark criteria omitting customer orientation, theory and competition,43 one met five criteria but did not report against customer orientation, theory or insight,37 one met five criteria but did not report against theory, insight or exchange38 and one met five criteria: but did report use of theory, competition and segmentation.32 Finally, one intervention met four of the eight benchmarks, whilst not reporting against theory, insight, exchange and segmentation.40
Table 3.
Community base Chlamydia trachomatis (CT) interventions evaluated utilizing social marketing benchmark criteria
| Study | Coding against benchmark criteria |
|---|---|
|
Aldeen et al. (2010) UK38 |
|
|
Alicea‐Alvarez et al. (2011) US36 |
|
|
Anderson et al. (2002) Denmark41 |
|
|
Anderson et al. (2011) UK32 |
|
|
Barry et al. (2008) US37 |
|
|
Brabin et al. (2009) UK35 |
|
|
Chai et al. (2010) US40 |
|
|
Chen et al. (2007) Australia26 |
|
|
Emmerton et al. (2011) Australia33 |
|
|
Gaydos et al. (2006, 2009) US28, 29 |
|
|
Jones et al. (2007) South Africa42 |
|
|
Kwan et al. (2012) Australia43 |
|
|
Novak and Karlsson (2005) Sweden47 |
|
|
Oh et al. (2002) US46 |
|
|
Sacks‐Davis et al. (2010) Australia44 |
|
|
Scholes et al. (2007) US45 |
|
|
van Bergen et al. (2004) Netherlands34 |
|
|
Vaughan et al. (2010) Ireland30 |
|
|
van Bergen et al. (2010)30
van den Broek et al. (2010) Netherlands31 |
|
|
Wilkins and Mak (2007) Australia27 |
|
Of the interventions that had low‐modest impact, one met seven criteria but did not report use of theory,35 one met six criteria but did not report the use of theory or competition44 and one met six criteria but not competition and segmentation.46 Two of these interventions met four criteria but did not report customer orientation, theory, competition or segmentation,45, 47 and another met four criteria but did not feature the use of theory, insight, competition or segmentation.30
Behaviour
All 20 interventions had a specific behaviour goal of increasing participation in Chlamydia screening. Four interventions promoted opportunistic on‐site CT testing in clinics, in educational settings, in two universities38, 39 and in two high schools.36, 37 Another intervention randomized participants to on‐site testing at a youth centre or community health centre as part of a clinical trial42. All of these interventions promoted urine CT tests, except Aldeen et al.38 who offered a vaginal swab. Two interventions promoted screening at community health clinics and/or with a GP.26, 27
Fourteen interventions promoted home CT screening behaviours, via purchased32 or free CT kits from community pharmacies,33, 34, 35 at a music festival,44 a youth centre participating in a clinical trial,42 direct mail to participants41, 45 or online.28, 29, 30, 31, 40, 46, 47 Fifteen interventions promoted the use of urine CT tests kits. Three promoted use of vaginal swabs,28, 29, 41, 42 while one43 provided urine tests for men and vaginal swab tests for women. Only one intervention (reported in two papers) provided users a choice of vaginal or urine testing.30, 31
Customer orientation
Only eight interventions reported the conduct of primary formative research with the target audience prior to design and implementation. This included the use of interviews,33 surveys,44 focus groups,26, 28, 29, 46 pre‐testing of campaign messages26, 46 and the conduct of pilot interventions.30, 31, 32, 35, 46 Three others interventions demonstrated limited customer orientation during and after the intervention via the conduct of process and audience impact evaluation.26, 39, 42, 44, 46 Only one study reported on data collected from those who both participated in screening and those who did not.28, 29 The remaining interventions reported very limited customer orientation via their reference to secondary sources to inform design.36, 37, 38, 40
Theory
According to this benchmark, interventions should be informed by relevant behavioural theories that are used to understand the target behaviour. Only two included interventions identified the use of theory. Sacks‐Davis et al.44 referred to the Health Belief Model and Oh et al.46 to the Theory of Reasoned Action and the Media Practice Model as theoretical frameworks. However, neither explicitly stated how these theories were applied to the design, conduct or evaluation of the interventions.
Insight
Those interventions that conducted formative research highlighted the following insights into their target audiences: difficulty accessing issues to medical settings and the appeal testing in non‐medical environments,32, 39 the attitudes of clientele attending music festivals44 and barriers to staff delivering CT screening in the pharmacy setting.33
Other interventions referenced only existing research to provide insight into target audience barriers and motivators to undertaking the CT screening. For example, barriers to testing in young people, such as costs, clinic waiting times, inconvenience, fear of medical procedure, stigma, and lack of privacy, stigma, embarrassment and a lack of routine testing by GPs27, 28, 29 and the need to correct misinformation about CT.46 Motivators for seeking CT testing such as exposure of adolescents to information on CT and a young person's sense of self and lived experience were also identified in a single study.46
Exchange
All of the reviewed studies sought to minimize costs associated with behaviour change to make it more attractive to the individual. All except one32 addressed the monetary cost involved in screening by providing free tests/kits. Mitigating other costs (e.g. time, effort) was addressed more comprehensively in some interventions than others. For example, to promote the uptake of home CT screening behaviours, some interventions distributed kits directly by mail to participants,41, 45 while others necessitated time and effort to request a kit via a mailed form45 or online requests28, 29, 30, 40, 46, 47 or provided tests in more accessible locations.32
Interventions also addressed barriers to specimen delivery to a laboratory by mail32, 33, 34 or by onsite processing.37 Access barriers to receiving results were addressed by sending results via use of phone, SMS, email or post and access to treatment also by post44. Other barriers of access addressed included transport, health insurance and confidentiality.40 It is also likely that many of these home‐based interventions also overcame some of the embarrassment or stigma associated with asking for and receiving a CT test – although this was not reported against in any of the studies.
In terms of offering incentives or benefits, most interventions highlight the benefits of screening and treatment, for example a sense of relief and peace of mind by taking a test.39 Others interventions offered, prizes (from $10‐$80) issued randomly and treatment services offered at times and locations convenient to students,37 cold drinks, lollipops, a prize draw for MP3 player, CD vouchers,44 access to free, anonymous, easy to access and private screening process,39 soft drink, water and class leave passes36 and volunteers offered monetary vouchers as incentives.36, 39
Competition
All of the interventions sought to enhance the exchange for the target audience by addressing the barriers of access to screening in the primary care setting by utilizing non‐clinical settings (e.g. music festivals or pharmacies), or via establishing a presence in an online environment. For example, use of home‐based kits addressed both internal barriers (e.g. fear of pelvic examination, embarrassment) and external barriers (time to visit clinic, costs, parental involvement).28, 29 Alicea‐Alvarez et al.36 directly addressed the competing behaviour of ‘attending class’ by offering ‘passes’ to attend the school clinic. Wilkins and Mak27 also used reminders in recognition that participants’ may be distracted or forget about screening.
Segmentation
With the exception of four interventions, two of which were set in pharmacies,27, 32, 33, 43, 47 all interventions defined specific target audiences for their programme. Eight were defined on the basis of age,26, 27, 30, 37, 41, 44, 46 one on gender,45 four on age and gender29, 34, 35, 36, 40 and one targeting attendees at a University.38 Geographic segments were also targeted including schools within disadvantaged or rural communities in two interventions,36, 37, 39 at a regional level41 and another at a state level.26 Finally, one intervention targeted attendees at a music festival.44 Whilst tailoring of the programmes to meet the specific needs of these segments may have occurred in the design of the programmes. Unfortunately, if or how this was done was not made explicit within the reporting of most of the articles. Three exceptions included Alicea‐Alvarez et al.36 who discussed the development of gender‐specific messages and materials for adolescent girls in a rural setting, and two other interventions, which reported tailoring resources for GPs and community.26, 27
Methods mix
Social marketing interventions do not rely solely on education, but utilize the breadth of the marketing mix: product, price, place and promotion.
Product
‘Product’ refers to the desired behaviour (actual product) and the set of benefits associated with the desired behaviour (core product).18 In this study, the use of a CT screening test is the desired behaviour (actual product), whilst the benefits that people accrue from screening use such as confidential free treatment, avoiding infertility caused by Chlamydia, or not infecting future partners are core products. The mostly commonly promoted actual product was home‐based urine test kit,32, 35, 40, 43, 44, 47 and urine tests which could be taken in ‘alternative’ settings.36, 37, 39, 42 Vaginal swabs were less frequently promoted both for home use28, 29, 41, 42, 43 and in one alternative on‐campus setting.38 Only one intervention provided users a choice or vaginal or urine testing.30, 31 Two interventions also promoted screening at community health clinics and/or with a GP, but did not specify the type of test.26, 27
Augmented products are the features that encourage uptake of an actual product or service. In this case, augmented products are those that support people in their use of the promoted CT screening test. In the interventions products used to support the use CT testing included interactive websites, phone information lines, information resources (on screen and printable), referral support (print outs or phone support) and partner notification services (online).
Supportive online features included facilities to assist participants to calculate risk scores, ‘Question and Answer’ educational information, results notification services45, 47 and an email facility for anonymous partner notification.30, 31 Phone services offered with some interventions included a recorded information line, staff supported information lines,32 counselling services and results notification services.32, 33, 39, 40, 44 These services offered information (and/or support) at various points including prior to screening, to communicate results and to support access to treatment or discuss results. Interventions in alternative non‐medical clinics within educational settings may have also provided trained personnel as an augmented service to support the uptake of screening in the target audiences,36, 37, 38, 39 although this was not clearly described.
Price
Price was addressed within the interventions in the following ways: the provision of a free test kit, or free treatment (addressing monetary costs), and providing testing in a non‐clinical home or educational setting; the use of direct mail for distribution of tests kits, online, phone or post results notification, phone information, support and advice lines; post‐treatment support including partner notification services (all addressing psychological and time costs).
Place
In regards to the ‘where’ of CT service use, the ‘actual product’ section of this paper has detailed how the ‘where’ component of screening (home based vs. clinic based screening) can influence uptake of screening behaviours.
Communication channels
The interventions used a variety of strategies including brochures, leaflets, posters and cards in 14 interventions.26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 37, 40, 41, 45, 46 Four of these distributed promotions via direct mail,30, 31, 41, 45, 46 seven via mass or narrow cast media (e.g. radio, TV, email alerts and video ads at sporting grounds).26, 27, 28, 29, 39, 40, 46, 47 In‐class presentations were also utilized in high‐school settings36, 37 and at youth groups and public health clinics.42 Websites were utilized in eight interventions,27, 28, 29, 30, 31, 40, 42, 43, 47 interpersonal channels in pharmacy settings32, 33 and at the music festival.44
Promotion
Not all the interventions specified promotional messages that were utilized as part of their programme. Of those with associated websites mentioned in publications describing included interventions, the following messages were identified. Firstly, “I want the kit’40 focusing on how participants could obtain free Chlamydia testing. Another, “Most people don't have a clue” focused on lack of knowledge about Chlamydia.27 This intervention also used rotating comic book style images with slogans including “Could my partner have it?’, ‘Could I be infertile?’, ‘My package looks good but could I have it?’ and ‘Could I have it again?’ to engage people at risk but potentially unaware. This intervention also used radio buttons highlighting where to get Chlamydia information and especially ‘Free testing’.
The ‘Get the Facts’ Website43 focused on information including signs and symptoms, risk factors and the need to get tested and treated. Vaughan et al.,39 also promoted Chlamydia screening during the Annual Sexual Health and Awareness and Guidance (SHAG) Week. However, no specific Chlamydia campaign materials could be identified via the website.
Discussion
To our knowledge, this is the first systematic review of community‐based Chlamydia screening interventions in a range of non‐clinical settings, and the first to utilize the social marketing benchmark criteria as a framework to evaluate the nature, strategies and outcomes of interventions against behavioural goals. This systematic review identified 20 articles examining the effectiveness of interventions to engage young adults in community‐based (non‐medical) settings to participate in CT screening. Whilst the overall quality of evidence available was low (including variations in study design, numbers of participants and a variation in the methods utilized to collect evaluation data), a descriptive systematic review of current approaches to promoting screening behaviours in community settings remains useful, generating lessons to be drawn to inform future research and intervention designs.
Overall, the results in regard to the potential effectiveness of community‐based interventions to promote CT screening in young people are promising. Across all of the interventions, 15 reported achieving high proportional screening rates26, 27, 29, 30, 32, 34, 41, 42, 44 when compared to rates within primary care settings in countries such as Australia. This suggests that screening promoted in community‐based settings may overcome some of the barriers to screening performed in health and medical clinics. All interventions that offered an alternative ‘clinic’ in educational settings resulted in higher rates of screening than is typical in the primary care setting, whilst those promoting home‐based tests produced mixed results with some higher and some lower rates than primary care. This suggests there may still be value to the target audience in face‐to‐face, supported screening and that overcoming some of the time, access and psychological barriers of traditional medical clinics may be effective in increasing participation in screening.
Four interventions also achieved a higher positivity rate than is currently observed in sexual health clinics.48 Three of these four interventions included a formal risk assessment for participants as part of the strategy to promote testing in higher risk groups,27, 40, 43 suggesting that the incorporation of such a programme feature may be important to reach higher risk segments of the population.
In relation to promoting screening that leads to treatment of Chlamydia, only four included interventions reported the proportion of those who accessed treatment following a positive test result (ranging between 47.1 and 91%).32, 35, 39, 43 Therefore, the effectiveness of community‐based screening as a pathway to treatment is less certain. This is important because an analysis of the intervention strategies shows a tendency of community interventions to only address the ‘cost’ of screening by focusing on improving access to ‘a kit’ and also to results. However, the barriers (time and psychological) that exist for young people to presenting to a medical clinic for treatment remain and were addressed in only one of the interventions, which also provided treatment by post.
Overall, the systematic review suggests that those programmes in a community setting that incorporated a greater range of strategies consistent with social marketing principles were likely to achieve more positive results (even if they were not planned with, or self‐identified as using the social marketing framework). This demonstrates the utility and potential of social marketing in the development of community‐based CT interventions. Furthermore, the social marketing benchmark criteria present a useful evaluation tool.
The systematic review also identified that interventions did not comprehensively utilize social marketing as a strategic framework. This is not surprising given that most included interventions were not self‐identified as social marketing. Given its effectiveness as a behaviour change approach, the analysis presented here generates useful insight that can inform the development and implementation of future CT screening interventions. A key finding was that included interventions often failed to use or failed to report use of formative research. Therefore, CT screening interventions should place a greater emphasis on formative research to understand the attitudinal and behavioural segments within the target audience. This should improve insight and opportunities for segmenting and tailoring interventions. Segmentation of the target audiences in the majority of the interventions was defined on the basis of age (range 14–29) and geographic region; only five specified a gender target group. Whilst tailoring of the programmes to meet the specific needs of these segmentation may have occurred in the design of the programmes – unfortunately, how this was done was not made explicit within the reporting of included studies. There was also no evidence of targeting of interventions to minority ethnic groups or other more vulnerable populations other than on the basis of geographic region.36, 37 Given the known differences in attitudes, stigma and health behaviours between genders and cultures, this is surprising, highlighting the need for consideration of programmes targeted and towards these market segments. Interestingly, two interventions also targeted on the basis of other behaviours (e.g. attendance at a University health clinic and purchase of oral contraceptives). Results from these two studies were both mixed, suggesting the need for further research to explore the value of ‘coupling’ CT screening with other behaviours.
Few existing CT screening interventions currently reported using behavioural theory in their design and implementation. Given the efficacy of use of theory to inform behaviour change programmes in other domains, future CT screening interventions should be theoretically framed. Post‐intervention process analysis of ‘why’ people did or did not participate would also offer insight.
Further research on young people from culturally and linguistically diverse also appears warranted. Finally, few current interventions adequately address the competition to the desired behaviour. Research to identify why a particular target segments do not present for screening and helping to identify competitive behaviours and influences should be a component of future CT screening programmes.
Conclusion
Whilst the quality of evidence remains low for current approaches, a systematic review of community‐based interventions to promote CT screening in young people <30 years suggests the potential utility of strategic community‐based social marketing interventions across a range of settings to promote screening at higher rates than currently exist in primary care for this target group. The use of clinics in educational settings (which overcome the barriers of time and cost of visiting a medical clinic) suggests the value of face‐to‐face support and interaction for some young people. The use of risk assessment tools also shows promise in community settings to increase positivity rates. Evaluation of programme strategies according to social marketing benchmark criteria highlighted that whilst few comprehensively incorporated all social marketing principles those that did incorporate, a greater range of strategies were likely to be effective. Given its effectiveness as a strategic approach to promote health behaviour change, the use of social marketing to develop future CT screening interventions holds potential to improve outcomes. Formative research to increase insight, facilitate engagement and enable segmentation and tailoring of screening interventions may also improve outcomes. Finally, robust evaluation is required to provide evidence of the efficacy of CT social marketing interventions and generate further insight on effective strategies for engaging young people.
Conflict of interest
None.
Funding
This work was supported by a small grant from the HIV/AIDS Related Programs Unit (HARP) (Illawarra Shoalhaven Local Health District) to assess the approaches and effectiveness of published behavioural interventions for Chlamydia screening.
Acknowledgements
Nil.
Correction added on 10 February 2015, after first publication: Ross Gordon's affiliation should read as Senior Lecturer, Marketing and Managements, Macquarie University, Sydney, NSW, Australia
Note
Interventions targeting Chlamydia in addition to other health issues were excluded, as Chlamydia is largely asymptomatic and therefore the focus of interventions is distinct.
References
- 1. Australian Institute of Health and Welfare (AIHW) . Australia's Health 2012. Australia's health series no.13. Cat. no. AUS 156. Canberra, ACT: AIHW, 2012. [Google Scholar]
- 2. Eurosurveillance . Genital chlamydia now the most commonly diagnosed sexually transmitted infection in England, Wales, and Northern Ireland. Euro Surveillance 2002;6:pii=1863. [Google Scholar]
- 3. Low N; SCREen project team . Publication of report on chlamydia control activities in Europe. Euro Surveillance, 2008; 13: 18924. [PubMed] [Google Scholar]
- 4. Peipert JF. Genital chlamydial infections. New England Journal of Medicine, 2003; 349: 2424–2430. [DOI] [PubMed] [Google Scholar]
- 5. Australian Government Department of Health . Second National Sexually Transmissible Infection Strategy: 2010‐2013. Canberra, ACT: Australian Government Department of Health and Ageing, 2010. [Google Scholar]
- 6. Workowski KA. Sexually transmitted infections and HIV: diagnosis and treatment. Topics in Antiviral Medicine, 2012; 20: 11–16. [PMC free article] [PubMed] [Google Scholar]
- 7. U.S Preventative Services Task Force . Screening for chlamydial infection: recommendation statement. Annals of Internal Medicine, 2007; 147: 128–134. [DOI] [PubMed] [Google Scholar]
- 8. Taskforce RRB . Guidelines for Preventive Activities in General Practice. South Melbourne, Vic: Taskforce RRB, 2009. [Google Scholar]
- 9. European Centre for Disease Prevention and Control (ECDC) . Chlamydia Control in Europe. Stockholm: ECDC, 2009. [Google Scholar]
- 10. Kong FYS, Guy RJ, Hocking JS et al Australian general practitioner chlamydia testing rates among young people. Medical Journal of Australia, 2011; 194: 249–252. [DOI] [PubMed] [Google Scholar]
- 11. Centers for Disease Control (CDC) . 2012 Sexually Transmitted Diseases Surveillance. Available at: http://www.cdc.gov/std/stats12/ [Google Scholar]
- 12. European Centre for Disease Prevention and Control (ECDC) . Review of Chlamydia Control Activities in EU Countries. Stockholm: ECDC, 2008. [Google Scholar]
- 13. Guy RJ, Ali H, Liu B et al Efficacy of interventions to increase the uptake of chlamydia screening in primary care: a systematic review. BMC Infectious Diseases, 2011; 11: 211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Low N, Bender N, Nartey L, Shang A, Stephenson JM. Effectiveness of chlamydia screening: systematic review. International Journal of Epidemiology, 2009; 38: 435–448. [DOI] [PubMed] [Google Scholar]
- 15. Wackett J. A theory‐based initiative to reduce the rates of chlamydia trachomatis infection among young adults in the Yukon. The Canadian Journal of Human Sexuality, 1998; 7: 347–356. [Google Scholar]
- 16. Welsh Government . Sexual Health and Wellbeing Action Plan for Wales, 2010‐2015. Cardiff, Wales: Welsh Assembly Government, 2010. [Google Scholar]
- 17. Donovan R. The role for marketing in public health change programs. Australian Review of Public Affairs, 2011; 10: 23–40. [Google Scholar]
- 18. Kotler P, Roberto N, Lee N. Social Marketing: Improving the Quality of Life, 2nd edn Thousand Oaks, CA: Sage Publications, 2002. [Google Scholar]
- 19. Gordon R, McDermott L, Stead M, Angus K. The effectiveness of social marketing interventions for health improvements: what's the evidence? Public Health, 2006; 120: 1133–1139. [DOI] [PubMed] [Google Scholar]
- 20. Jamil MS, Guy RJ, Hocking JS et al Home‐based chlamydia and gonorrhoea screening: a systematic review of strategies and outcomes. BMC Public Health, 2013; 13: 189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. French J, Blair Stevens C. Social Marketing Pocket Guide, 1st edn London: National Social Marketing Centre, 2005. [Google Scholar]
- 22. Stead M, Gordon R, Angus K, McDermott L. A systematic review of social marketing effectiveness. Health Education, 2007; 107: 126–191. [Google Scholar]
- 23. Grier L, Bryant CA. Social marketing in public health. Annual Review of Public Health, 2005; 26: 319–339. [DOI] [PubMed] [Google Scholar]
- 24. Eadie D, MacKintosh A, MacAskill S, Brown A. Development and evaluation of an early detection intervention for mouth cancer using a mass media approach. British Journal of Cancer, 2009; 101: S73–S79. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Guyatt G, Oxman A, Vist G, Kunz R, Falck‐Ytter Y, Schunemann H. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. British Medical Journal, 2008; 336: 924–926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Chen MY, Karvelas M, Sundararajan V, Hocking JS, Fairley CK. Evidence for the effectiveness of a chlamydia awareness campaign: increased population rates of chlamydia testing and detection. International Journal of STD and AIDS, 2007; 18: 239–243. [DOI] [PubMed] [Google Scholar]
- 27. Wilkins A, Mak D. Sending out an SMS: an impact and outcome evaluation of the Western Australian Department of Health's 2005 chlamydia campaign. Health Promotion Journal of Australia, 2007; 18: 113–120. [DOI] [PubMed] [Google Scholar]
- 28. Gaydos CA, Barnes M, Aumakhan B et al Can E‐technology through the internet be used as a new tool to address the chlamydia trachomatis epidemic by home sampling and vaginal swabs? Sexually Transmitted Diseases, 2009; 36: 577–580. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Gaydos CA, Dwyer K, Barnes M et al Internet‐based screening for Chlamydia trachomatis to reach non‐clinic populations with mailed self‐administered vaginal swabs. Sexually Transmitted Diseases, 2006; 33: 451–457. [DOI] [PubMed] [Google Scholar]
- 30. van Bergen JE, Fennema JS, van den Broek IV et al Rationale, design, and results of the first screening round of a comprehensive, register‐based, Chlamydia screening implementation programme in the Netherlands. BMC Infectious Diseases, 2010; 10: 293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. van den Broek IV, Hoebe CJ, van Bergen JE et al Evaluation design of a systematic, selective, internet‐based, Chlamydia screening implementation in the Netherlands, 2008‐2010: implications of first results for the analysis. BMC Infectious Diseases, 2010; 10: 89. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Anderson C, Thornley T. A pharmacy‐based private chlamydia screening programme: results from the first 2 years of screening and treatment. International Journal of Clinical Pharmacy, 2011; 33: 88–91. [DOI] [PubMed] [Google Scholar]
- 33. Emmerton L, Skinner M, Gardiner E, Nissen L, Debattista J. A trial of the distribution of Chlamydia self‐collection postal specimen kits from Australian community pharmacies. Sexual Health, 2011; 8: 130–132. [DOI] [PubMed] [Google Scholar]
- 34. van Bergen J, Postma MJ, Peerbooms PGH, Spangenberg AC, Tjen‐A‐Tak J, Bindels PJE. Effectiveness and cost‐effectiveness of a pharmacy‐based screening programme for Chlamydia trachomatis in a high‐risk health centre population in Amsterdam using mailed home‐collected urine samples. International Journal of STD & AIDS, 2004; 15: 797–802. [DOI] [PubMed] [Google Scholar]
- 35. Brabin L, Thomas G, Hopkins M, O'Brien K, Roberts SA. Delivery of chlamydia screening to young women requesting emergency hormonal contraception at pharmacies in Manchester, UK: a prospective study. BMC Womens Health, 2009; 9: 7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Alicea‐Alvarez N, Hellier SD, Jack LW, Lundberg GG. A pilot study of chlamydia screening among high school girls. Journal for Nurse Practitioners, 2011; 7: 25–28. [Google Scholar]
- 37. Barry PM, Scott KC, McCright J et al Stay in school? Results of a sexually transmitted diseases screening program in San Francisco high schools‐2007. Sexually Transmitted Diseases, 2008; 35: 550–552. [DOI] [PubMed] [Google Scholar]
- 38. Aldeen T, Jacobs J, Powell R. Screening university students for genital chlamydial infection: another lesson to learn. Sexual Health, 2010; 7: 491–494. [DOI] [PubMed] [Google Scholar]
- 39. Vaughan D, O'Connell E, Cormican M et al “Pee‐in‐a‐Pot”: acceptability and uptake of on‐site chlamydia screening in a student population in the Republic of Ireland. BMC Infectious Diseases, 2010; 10: 325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Chai SJ, Aumakhan B, Barnes M et al Internet‐based screening for sexually transmitted infections to reach nonclinic populations in the community: risk factors for infection in men. Sexually Transmitted Diseases, 2010; 37: 756–763. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Andersen B, Olesen F, Moller JK, Ostergaard L. Population‐based strategies for outreach screening of urogenital Chlamydia trachomatis infections: a randomized, controlled trial. Journal of Infectious Diseases, 2002; 185: 252–258. [DOI] [PubMed] [Google Scholar]
- 42. Jones HE, Altini L, de Kock A, Young T, van de Wijgert J. Home‐based versus clinic‐based self‐sampling and testing for sexually transmitted infections in Gugulethu, South Africa: randomised controlled trial. Sexually Transmitted Infections, 2007; 83: 552–557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Kwan K, Jachimowicz E, Bastian L, Marshall L, Mak D. Online chlamydia testing: an innovative approach that appeals to young people. Medical Journal of Australia, 2012; 197: 287–290. [DOI] [PubMed] [Google Scholar]
- 44. Sacks‐Davis R, Gold J, Aitken CK, Hellard ME. Home‐based chlamydia testing of young people attending a music festival–who will pee and post? BMC Public Health, 2010; 10: 376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Scholes D, Heidrich FE, Yarbro P, Lindenbaum JE, Marrazzo JM. Population‐based outreach for Chlamydia screening in men: results from a randomized trial. Sexually Transmitted Diseases, 2007; 34: 837–839. [DOI] [PubMed] [Google Scholar]
- 46. Oh MK, Grimley DM, Merchant JS, Brown PR, Cecil H. Hook Iii EW. Mass media as a population‐level intervention tool for Chlamydia Trachomatis screening: report of a pilot study. Journal of Adolescent Health, 2002; 31: 40–47. [DOI] [PubMed] [Google Scholar]
- 47. Novak DP, Karlsson RB. Simplifying chlamydia testing: an innovative Chlamydia trachomatis testing approach using the internet and a home sampling strategy: population based study. Sexually Transmitted Infections, 2006; 82: 142–147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. National Centre in HIV Epidemiology and Clinical Research . HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia Annual Surveillance Report 2009. Sydney, NSW: National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, 2009. [Google Scholar]
